News

A recent study has estimated the seroprevalence of hepatitis C virus (HCV) infection to be 0.5% in the antenatal population.

With vaccine supplies at alarmingly low levels a potential public health emergency of global proportions may be on the horizon.

In a webinar presented on June 9 by The Department of Health and Human Services (HHS) Working Group on Lyme and Other Tick-borne Diseases, a panel of speakers discussed trends in tick-borne diseases (TBDs) in the United States.

US travelers concerned about contracting cholera during overseas journeys to areas where the disease remains a threat may now have options as they seek to reduce their risk.

A recent review focuses on the biology of human papillomaviruses, their associated burdens, and the clinical data available on HPV vaccine efficacy.

Sequirus recently announced that the US Food and Drug Administration (FDA) has approved Flucelvax Quadrivalent influenza vaccine.

Hepatitis C virus (HCV) cure when using direct-acting antiviral (DAA) agents in human immunodeficiency virus (HIV)-coinfected patients is lower in real-world settings than when patients are enrolled in clinical trials, a new study has found.

A long-held belief regarding the way in which vaccinations work to protect hosts from pathogens may be inaccurate.

Researchers at McGill University in Montreal revealed that the gene editing tool known as CRISPR/Cas9, which had previously been shown to hold some promise in removing HIV-infected cells from the human genome, may in fact be a “double-edged sword.”

This article seeks to review newer ART agents, as well as those in later stages of drug development, for the treatment of HIV-1 infection.

An international team of researchers may have identified a potential animal model for use in the laboratory as part of efforts to better understand the pathogenesis of Middle East respiratory syndrome (MERS) coronavirus and, hopefully, find an effective treatment for it: alpacas.

In an effort to contain the Zika virus, the Centers for Disease Control and Prevention (CDC) is holding a series of teleconferences regarding concerns that were raised during the Zap Zika conference held in early April. The fifth conference in the series discusses Zika epidemiology.

Wet steam processing of fruits has the potential to significantly reduce the incidence of food-borne illness associated with contaminated fresh-cut fruits, a new study has suggested.

A new report from the Centers for Disease Control and Prevention (CDC) suggests that many of the reported outbreaks involving Legionella bacteria since 2000 could have been prevented with better testing protocols and infrastructure management.

Contagion has launched a global Outbreak Monitor that allows users to visualize occurrences of infectious diseases, such as Zika and Yellow Fever, on a local, regional, national and international level.

Public health demands integrity, said Margaret Hamburg, MD, former commissioner of the US Food and Drug Administration (FDA), at the Centers for Disease Control and Prevention’s 65th Annual Epidemic Intelligence Service (EIS) Conference in Atlanta, Georgia.

Incidence of syphilis is on the rise in Europe—particularly among men—according to a report released in May by the European Centre for Disease Prevention and Control (ECDC).

Recent studies on Zika have lead researchers to discover how the virus causes neurological complications, as well as ways in which the body can fight off the infection.

The FDA recently granted Emergency Use Authorization for the Idylla Ebola Virus Triage Test, a diagnostic test which detects the presence of the virus in blood.

Each year, norovirus infection is responsible for an estimated 684 million episodes of diarrhea and 212,000 deaths worldwide, and results in approximately $4.2 billion in healthcare costs and $60.3 billion in societal costs, a new report has highlighted.

With reports in the mainstream media prophesizing doom with regard to the issue of antimicrobial resistance, a committee formed by the British government has released a report designed to properly contextualize the crisis and develop recommendations for addressing it.

A recent review article on the status of vaccines in development for healthcare associated infections (HAIs) provides both an in-depth discussion of their urgent need, as well as their potential for success.

A recent report describing the development of “flesh-eating bacteria” in a Louisiana woman has the public concerned. The infection developed after the woman injured her foot, resulting in bleeding, while surf fishing in the Gulf of Mexico earlier this May.

In an open letter copied to the International Olympic Committee, 150 health experts from around the world urged the WHO Director-General, Margaret Chan, MD, MPH, to either postpone or move both the Olympic and Paralympic Games, for the sake of public health.

Efforts to bring to market a vaccine for the fight against Zika virus, at least via the private sector, have been stalled over concerns regarding the “marketability” of these products, according to multiple reports in the business press.

Management of visceral leishmaniasis poses a daunting challenge, in part due to the side effects associated with the use of the traditional treatment. However, one vaccine development strategy has recently shown promising results.

For the first time, a recent study has captured African monkeys eating bats—a finding that raises concern about the spread of zoonotic diseases such as Ebola.

A recently published article in an Indian newspaper claims that thousands of civilians living across the country have contracted HIV through blood transfusions, in less than two years; however, a national AIDS organization is refuting these claims.

In an attempt to provide the best possible care for her unborn child, a Honduras woman with suspected Zika infection traveled to the United States where she then gave birth to a baby with microcephaly at Hackensack University Medical Center.

A recent study in treatment-naïve patients with chronic hepatitis C virus (HCV) infection has shown that ledipasvir/sofosbuvir (LDV/SOF) combination therapy produces similar sustained virologic response (SVR) rates in clinical trial-based studies and real-world studies.